leupeptin has been researched along with chlorhexidine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Furuichi, Y; Nagasawa, T; Nakatsuka, Y; Nakazawa, F; Yumoto, Y | 1 |
2 other study(ies) available for leupeptin and chlorhexidine
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Inhibitory effects of sword bean extract on alveolar bone resorption induced in rats by Porphyromonas gingivalis infection.
Topics: Adhesins, Bacterial; Alveolar Bone Loss; Animals; Bacteroidaceae Infections; Canavalia; Canavanine; Chlorhexidine; Chromatography, High Pressure Liquid; Cystatins; Cysteine Endopeptidases; Disease Progression; Epithelial Cells; Gingipain Cysteine Endopeptidases; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; KB Cells; Leupeptins; Male; Microbial Sensitivity Tests; Mouth Mucosa; Phytotherapy; Plant Extracts; Porphyromonas gingivalis; Rats; Rats, Wistar; Specific Pathogen-Free Organisms | 2014 |